JP2005506354A - 癌治療のためのオリゴアミン化合物およびその誘導体 - Google Patents

癌治療のためのオリゴアミン化合物およびその誘導体 Download PDF

Info

Publication number
JP2005506354A
JP2005506354A JP2003536196A JP2003536196A JP2005506354A JP 2005506354 A JP2005506354 A JP 2005506354A JP 2003536196 A JP2003536196 A JP 2003536196A JP 2003536196 A JP2003536196 A JP 2003536196A JP 2005506354 A JP2005506354 A JP 2005506354A
Authority
JP
Japan
Prior art keywords
compound
chohch
group
another embodiment
butyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003536196A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005506354A5 (fr
Inventor
ベンジャミン フライドマン，
アルドニア エル． バラシナス，
アンドレイ ブイ． ブロックヒン，
ヒラク エス． バス，
ロウレンス ジェイ． マートン，
ベノドハー ケイ． レディー，
Original Assignee
スリル バイオメディカル コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by スリル バイオメディカル コーポレイション filed Critical スリル バイオメディカル コーポレイション
Publication of JP2005506354A publication Critical patent/JP2005506354A/ja
Publication of JP2005506354A5 publication Critical patent/JP2005506354A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/18—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with hydroxy groups and at least two amino groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/14—Amines containing amino groups bound to at least two aminoalkyl groups, e.g. diethylenetriamines

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
JP2003536196A 2001-10-16 2002-10-16 癌治療のためのオリゴアミン化合物およびその誘導体 Pending JP2005506354A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32998201P 2001-10-16 2001-10-16
PCT/US2002/032932 WO2003033455A1 (fr) 2001-10-16 2002-10-16 Composes oligoamine et leurs derives pour le traitement des cancers

Publications (2)

Publication Number Publication Date
JP2005506354A true JP2005506354A (ja) 2005-03-03
JP2005506354A5 JP2005506354A5 (fr) 2009-01-15

Family

ID=23287844

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003536196A Pending JP2005506354A (ja) 2001-10-16 2002-10-16 癌治療のためのオリゴアミン化合物およびその誘導体

Country Status (7)

Country Link
US (3) US20030130356A1 (fr)
EP (1) EP1436246A1 (fr)
JP (1) JP2005506354A (fr)
AU (2) AU2002340224B2 (fr)
CA (1) CA2463771A1 (fr)
IL (1) IL161428A0 (fr)
WO (1) WO2003033455A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011503050A (ja) * 2007-11-08 2011-01-27 イッサム リサーチ ディべロップメント カンパニー オブ ザ ヘブライ ユニバーシティー オブ エルサレム，リミテッド スフィンゴリピドの新規合成アナログ

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002543163A (ja) * 1999-04-30 2002-12-17 スリル バイオメディカル コーポレイション 癌および前立腺疾患のための治療としての結合体
CA2371625C (fr) * 1999-04-30 2012-04-17 Slil Biomedical Corporation Analogues de polyamine a conformation restreinte utilises pour traiter des maladies
JP2005506354A (ja) * 2001-10-16 2005-03-03 スリル バイオメディカル コーポレイション 癌治療のためのオリゴアミン化合物およびその誘導体
WO2003050072A1 (fr) 2001-12-07 2003-06-19 Slil Biomedical Corporation Polyamines substituees par un cycloalkyle pour le traitement du cancer, et procedes de synthese de celles-ci
WO2004002991A1 (fr) * 2002-06-26 2004-01-08 Cellgate, Inc. Conjugue de porphyrine-polyamine pour la cancerotherapie
US7095075B2 (en) * 2003-07-01 2006-08-22 Micron Technology, Inc. Apparatus and method for split transistor memory having improved endurance
US7241654B2 (en) * 2003-12-17 2007-07-10 Micron Technology, Inc. Vertical NROM NAND flash memory array
US7075146B2 (en) * 2004-02-24 2006-07-11 Micron Technology, Inc. 4F2 EEPROM NROM memory arrays with vertical devices
EP1799200A1 (fr) * 2004-10-04 2007-06-27 Cellgate, Inc. Analogues de polyamine comme agents therapeutiques pour maladies oculaires
WO2006086773A2 (fr) * 2005-02-11 2006-08-17 Cellgate, Inc. Analogues de polyamine en tant que modulateurs de la migration cellulaire et de la motilite cellulaire
US20070232677A1 (en) * 2006-03-14 2007-10-04 Marton Laurence J Treatment and prevention of vascular hyperplasia using polyamine and polyamine analog compounds
FR2932088B1 (fr) * 2008-06-06 2013-04-05 Lvmh Rech Utilisation d'un extrait de lepechinia caulescens comme agent cosmetique, et composition cosmetique le contenant
US10815276B2 (en) 2014-05-21 2020-10-27 Entrada Therapeutics, Inc. Cell penetrating peptides and methods of making and using thereof
JP6807831B2 (ja) 2014-05-21 2021-01-06 エントラーダ セラピューティクス，インコーポレイテッド 細胞膜透過性ペプチド、並びにこの作製方法及び使用方法
EP3185880B1 (fr) 2014-08-27 2020-02-12 Ohio State Innovation Foundation Inhibiteurs améliorés de la peptidyl-calcineurine
WO2019148194A2 (fr) 2018-01-29 2019-08-01 Ohio State Innovation Foundation Inhibiteurs peptidyliques de l'interaction calcineurine-nfat
EP3755351A4 (fr) 2018-02-22 2021-11-24 Entrada Therapeutics, Inc. Compositions et méthodes de traitement de l'encéphalopathie mitochondriale neurogastro-intestinale

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0186473A2 (fr) * 1984-12-27 1986-07-02 Mobil Oil Corporation Composés contenant des liaisons amides d'acides mono- et polycarboxyliques dans la même molécule, lubrifiants et combustibles les contenant
WO1999043752A1 (fr) * 1998-02-27 1999-09-02 Dnavec Research Inc. Compositions pour transporter des substances chargees negativement
WO2000066175A2 (fr) * 1999-04-30 2000-11-09 Slil Biomedical Corporation Nouveaux conjugues d'analogue de polyamine et conjugues de quinone, utilises pour le traitement de cancers et de maladies de la prostate

Family Cites Families (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2440724A (en) 1944-10-27 1948-05-04 Commercial Solvents Corp Nu-substituted, 2-butene-1, 4-diamines, and process for preparing
US4013507A (en) 1973-09-18 1977-03-22 California Institute Of Technology Ionene polymers for selectively inhibiting the vitro growth of malignant cells
US3956502A (en) 1974-09-04 1976-05-11 Nalco Chemical Company Polyamine alcohols as microbiocides
PL109855B1 (en) 1977-12-12 1980-06-30 Bath for electro-galvanizing and polishing
US4661509A (en) 1982-09-28 1987-04-28 Gordon Arnold Z Methods for treating leukopenia
US4551550A (en) 1983-12-06 1985-11-05 Merrell Dow Pharmaceuticals Inc. N-2,3-Butadienyl-1,4-butanediamine derivatives
CS252771B1 (cs) * 1986-01-20 1987-10-15 Josef Urbanek Reakční produkty vyšších nasycených a/nebo nenasycených karboxylových kyselin s polytopickými aminy
US4889851A (en) 1986-11-21 1989-12-26 Fujisawa Pharmaceutical Co, Ltd. Benzothiadiazine compounds, and pharmaceutical composition comprising the same
US5091576A (en) 1986-12-02 1992-02-25 University Of Florida Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
US5342945A (en) 1986-12-02 1994-08-30 University Of Florida Research Foundation, Inc. Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
US5677351A (en) 1986-12-02 1997-10-14 University Of Florida Research Foundation, Inc. Sterically hindered tetraamines and method for their production
US5393757A (en) 1986-12-02 1995-02-28 University Of Florida Polyamines and anti-diarrheal and gastrointestinal anti-spasmodic pharmaceutical compositions and methods of treatment
USRE38417E1 (en) 1986-12-02 2004-02-03 University Of Florida Research Foundation, Inc. Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives
US6184232B1 (en) 1986-12-02 2001-02-06 University Of Florida Analogs of biologically active, naturally occurring polyamines, pharmaceutical compositions and methods of treatment
US5654484A (en) 1987-10-08 1997-08-05 Merrell Pharmaceuticals Inc. Polyamine derivatives as antineoplastic agents
US4868219A (en) 1988-04-07 1989-09-19 Thornfeldt Carl R Treatment of skin diseases with aliphatic amines
CA2011367C (fr) 1988-08-30 1997-07-08 Henry Ashjian Produits de reaction d'alkenylsuccinimides avec des acides ethylenediaminecarboxyliques comme detergents de carburant
US5719193A (en) 1989-05-23 1998-02-17 Merrell Pharmaceuticals, Inc. Method of potentiating cell-mediated immunity utilizing polyamine derivatives
US5283367A (en) 1989-08-30 1994-02-01 Ciba-Geigy Corporation Substituted 1,4-diamino-2-butene stabilizers
JP3007391B2 (ja) 1990-08-13 2000-02-07 花王株式会社 新規第４級アンモニウム化合物
GB9111794D0 (en) 1991-05-31 1991-07-24 Robins David J Antifungal compounds
HU9400503D0 (en) 1991-08-23 1994-05-30 Pfizer Synthetic aryl polyamines as excitatory amino acid neurotransmitter antagonists
US5185369A (en) 1991-08-23 1993-02-09 Pfizer Inc. Synthetic heteroaryl polyamines as excitatory amino acid neurotransmitter antagonists
US5242684A (en) 1991-10-25 1993-09-07 Isp Investments Inc. Antimicrobial, low toxicity, non-irritating composition comprising a blend of bis-quaternary ammonium compounds coprecipitated with a copolymer of vinylpyrrolidone and an acrylamido or vinyl quaternary ammonium monomer
US5512597A (en) 1991-11-08 1996-04-30 Alcon Laboratories, Inc. Polymeric quaternary ammonium compounds and their use as ophthalmic antimicrobials
US6051611A (en) 1991-11-08 2000-04-18 Alcon Laboratories, Inc. Polymeric quaternary ammonium compounds and their use as ophthalmic antimicrobias
US5530092A (en) 1992-01-13 1996-06-25 Dsm N.V. Dendritic macromolecule and the preparation thereof
GB9220921D0 (en) 1992-10-05 1992-11-18 Merrell Dow Pharma Polyamine derivatives as anticytomegaloviral agents
DE4306152A1 (de) 1993-02-27 1994-09-01 Hoechst Ag Positiv arbeitendes strahlungsempfindliches Gemisch und damit hergestelltes Aufzeichnungsmaterial
US5451347A (en) 1993-06-24 1995-09-19 Lumigen, Inc. Methods and compositions providing enhanced chemiluminescence from chemiluminescent compounds using dicationic surfactants
US5541230A (en) 1993-11-05 1996-07-30 Us Health Therapeutic polyamines
JPH08507548A (ja) 1993-12-27 1996-08-13 チバ−ガイギー アクチェンゲゼルシャフト 抗癌剤および抗原生動物剤として使用するための不飽和アミノ化合物
DE4403039A1 (de) 1994-01-28 1995-08-03 Schering Ag Oktaazamakrocyclen, deren Metallkomplexe, Verfahren zu deren Herstellung, diese Komplexe enthaltende Mittel sowie deren Verwendung in Diagnostik und Therapie
ES2118554T3 (es) 1994-01-28 1998-09-16 Dsm Nv Macromolecula dendritica y procedimiento para su preparacion.
JPH07228589A (ja) 1994-02-16 1995-08-29 Fuji Photo Film Co Ltd リン酸エステル誘導体およびそれを含有するハロゲン化銀写真感光材料
JPH07277964A (ja) 1994-04-08 1995-10-24 Nippon Kayaku Co Ltd 抗腫瘍剤
DE59505727D1 (de) 1994-11-12 1999-05-27 Basf Ag Verfahren zur herstellung von aminen aus verbindungen mit mindestens 3 cyanogruppen
FR2729852A1 (fr) 1995-01-30 1996-08-02 Oreal Composition reductrice comprenant un acide amine basique et un polymere cationique
EP0752465A1 (fr) 1995-06-01 1997-01-08 The Procter & Gamble Company Bétaine esters pour administration des alcools
EP0761680A3 (fr) 1995-09-12 1999-05-06 Ono Pharmaceutical Co., Ltd. Composés de tétrazole ayant une activité inhibante d'enzyme convertissant l'Interleukine-1bêta
US5869715A (en) 1995-09-27 1999-02-09 The Reagents Of The University Of California Polyfunctional cationic cytofectins
US5886051A (en) 1995-11-08 1999-03-23 University Of Florida Research Foundation, Inc. Methods and compositions for the treatment of neurodegeneration
US6126964A (en) 1996-01-04 2000-10-03 Mirus Corporation Process of making a compound by forming a polymer from a template drug
US5962533A (en) * 1996-02-06 1999-10-05 University Of Florida Research Foundation, Inc. Hydroxy polyamines
EP0884944B1 (fr) 1996-02-07 2001-11-28 Buckman Laboratories International, Inc. Compositions antimicrobiennes synergiques contenant un polymere ionene et un sel de dodecylamine, et leurs procedes d'utilisation
DE19621510A1 (de) 1996-05-29 1997-12-04 Basf Ag Dendritische stickstoffhaltige organische Verbindungen mit planar-chiralen oder axial-chiralen Endgruppen, ihre Herstellung und Verwendung
US6034129A (en) 1996-06-24 2000-03-07 Geltex Pharmaceuticals, Inc. Ionic polymers as anti-infective agents
DE19625982A1 (de) 1996-06-28 1998-01-02 Wella Ag Kosmetisches Mittel zur Haarbehandlung mit Dendrimeren
US5866016A (en) 1997-07-01 1999-02-02 Buckman Laboratories International, Inc. Methods and compositions for controlling biofouling using combinations of an ionene polymer and a salt of dodecylamine
US5958397A (en) 1996-07-22 1999-09-28 Schering-Plough Healthcare Products, Inc. Method and composition for protecting against jellyfish stings
US5906996A (en) 1996-08-21 1999-05-25 Murphy; Michael A. Tetramine treatment of neurological disorders
EP1459744A3 (fr) 1996-09-13 2004-12-15 University Of Florida Research Foundation, Inc. Procédé inhibant la biosynthèse de l'eif5a
EP0889112A1 (fr) 1996-10-22 1999-01-07 Tonen Corporation Composition d'huile lubrifiante pour transmissions automatiques
US6235794B1 (en) 1997-04-03 2001-05-22 University Of Florida Biologically active spermidine analogues, pharmaceutical compositions and methods of treatment
US6307102B1 (en) 1997-10-15 2001-10-23 Tosoh Corporation Amine catalyst for producing polyurethane and polyisocyanurate
US6046282A (en) 1998-01-06 2000-04-04 Air Products And Chemicals, Inc. Reactive diluents for polyamidoamine epoxy curatives
JP3996274B2 (ja) 1998-07-07 2007-10-24 電気化学工業株式会社 モノビニルアセチレンの製造方法
AU5241499A (en) 1998-07-31 2000-02-21 Health Research, Inc., The Method of treating cancer in patients having a deficiency in p53 tumor suppressor gene
AU1180300A (en) 1998-11-16 2000-06-05 Rohto Pharmaceutical Co., Ltd. Liquid ophthalmic preparations
JP3747355B2 (ja) 1998-12-21 2006-02-22 独立行政法人理化学研究所 鎖状ポリアミン系化合物及びポリアミン系抗ガン剤
US6649587B1 (en) 1999-04-30 2003-11-18 Slil Biomedical Corporation Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
US6673890B1 (en) 1999-07-16 2004-01-06 Basf Aktiengesellschaft Zwitterionic polyamines and process for their production
GB9920107D0 (en) 1999-08-26 1999-10-27 Avecia Ltd Fluidising agents
JP2001131449A (ja) 1999-11-01 2001-05-15 Matsushita Electric Ind Co Ltd インクジェット記録用インク
FR2802817B1 (fr) 1999-12-23 2002-10-11 Centre Nat Rech Scient Nouveaux inhibiteurs de glycosidases et leurs applications pharmacologiques, notamment pour traiter le diabete
WO2001051603A2 (fr) 2000-01-10 2001-07-19 Zetetic Research, Inc. Composition pharmaceutique et procede d'utilisation correspondant
US6444707B1 (en) 2000-08-22 2002-09-03 West Agro Topically applied hoof treatment composition and concentrate
CA2422531C (fr) 2000-09-19 2011-03-08 Dermal Therapy (Barbados) Inc. Compositions analgesiques topiques contenant des polyamines aliphatiques et modalites d'utilisation
US6545181B1 (en) 2000-10-24 2003-04-08 Pilot Chemical Holdings, Inc. Demulsifying compound and a method of breaking or inhibiting emulsions
AU2001297817A1 (en) 2000-11-08 2002-11-25 Eli Lilly And Company Antiviral therapies using polyamine or polyamine analog-amino acid conjugates
AU2002221417A1 (en) 2000-12-01 2002-06-11 The University Of British Columbia Copper chelators for treating ocular inflammation
US7754765B2 (en) 2000-12-01 2010-07-13 Radical Vision Therapeutics Inc Copper chelators for treating ocular inflammation
US6399662B1 (en) 2000-12-13 2002-06-04 University Of Florida Method and composition for the treatment of diarrhea and gastrointestinal spasms
US6635679B2 (en) 2001-05-14 2003-10-21 Akzo Nobel N.V. Methods and compositions for inactivating viruses
US6713653B2 (en) 2001-08-24 2004-03-30 E. I. Du Pont De Nemours And Company Polyamines and polymers made therewith
JP2005506354A (ja) 2001-10-16 2005-03-03 スリル バイオメディカル コーポレイション 癌治療のためのオリゴアミン化合物およびその誘導体
US6458795B1 (en) 2001-11-15 2002-10-01 University Of Florida Method and composition for treatment of irritable bowel disease
US7030126B2 (en) 2001-11-16 2006-04-18 Als Therapy Development Foundation, Inc. Use of polyamine analogs for amyotrophic lateral sclerosis
KR20040091014A (ko) 2002-02-07 2004-10-27 위스콘신 얼럼나이 리서어치 화운데이션 항암 요법과 병행해서 사용하기 위한 폴리아민 화합물 및조성물
US6881732B2 (en) 2002-06-13 2005-04-19 Chelator Llc Neuroprotection and cardioprotection afforded by chelators with high affinity and specificity for cations of first transition series elements
US7189865B2 (en) 2002-07-23 2007-03-13 Attenuon, Llc Thiomolybdate analogues and uses thereof
US20040019043A1 (en) 2002-07-23 2004-01-29 Dimitri Coucouvanis Thiomolybdate analogues and uses thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0186473A2 (fr) * 1984-12-27 1986-07-02 Mobil Oil Corporation Composés contenant des liaisons amides d'acides mono- et polycarboxyliques dans la même molécule, lubrifiants et combustibles les contenant
WO1999043752A1 (fr) * 1998-02-27 1999-09-02 Dnavec Research Inc. Compositions pour transporter des substances chargees negativement
WO2000066175A2 (fr) * 1999-04-30 2000-11-09 Slil Biomedical Corporation Nouveaux conjugues d'analogue de polyamine et conjugues de quinone, utilises pour le traitement de cancers et de maladies de la prostate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011503050A (ja) * 2007-11-08 2011-01-27 イッサム リサーチ ディべロップメント カンパニー オブ ザ ヘブライ ユニバーシティー オブ エルサレム，リミテッド スフィンゴリピドの新規合成アナログ

Also Published As

Publication number Publication date
AU2002340224B2 (en) 2008-11-27
US20090124832A1 (en) 2009-05-14
EP1436246A1 (fr) 2004-07-14
IL161428A0 (en) 2004-09-27
US20050080144A1 (en) 2005-04-14
WO2003033455A1 (fr) 2003-04-24
AU2009200639A1 (en) 2009-03-12
CA2463771A1 (fr) 2003-04-24
US7491849B2 (en) 2009-02-17
US20030130356A1 (en) 2003-07-10

Similar Documents

Publication Publication Date Title
US20090124832A1 (en) Oligoamine compounds and derivatives thereof for cancer therapy
US7453011B2 (en) Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
US9018258B2 (en) Substituted 1-benzylcycloalkylcarboxylic acids and the use thereof
RU2386614C2 (ru) Производные n-[фенил(пирролидин-2-ил)метил]бензамида и n-[(азепан-2-ил)фенилметил]бензамида, способ их получения и их применение в терапии
AU2002340224A1 (en) Oligoamine compounds and derivatives thereof for cancer therapy
TW442456B (en) Diaryl antimicrobial agents
EP1796681A2 (fr) Composes inhibant les amine oxydases contenant du cuivre, et utilisations correspondantes
TW200540169A (en) Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
CN100582084C (zh) 疏水性多胺类似物及其使用方法
NZ515140A (en) Conformationally restricted polyamine analogs as disease therapies for cancer, epilepsy, alzheimers, infections, grafts and others
JP2000501390A (ja) アミノ酸誘導体、これらの化合物を含む医薬組成物及びそれらの調製方法
CN1438991A (zh) 作为中性内肽酶的抑制剂的环戊基－取代的戊二酰胺衍生物
CN1184475A (zh) 具有mdr活性的四氢化萘化合物
JPH07500577A (ja) レトロウイルス性プロテアーゼ・インヒビター
JPH11503422A (ja) プロテアーゼを阻害するコハク酸誘導体
JP2001525399A (ja) 選択的β３アドレナリン作動性作動薬
JP2005533820A (ja) 癌治療のためのポルフィリン−ポリアミン結合体
JP2002540098A (ja) 三環性インドール−２−カルボン酸化合物
JP2002508739A (ja) 立体配座的に制限のあるポリアミン類
JP2001510179A (ja) 細胞救援剤としての脂肪族プロパルギルアミン類
JP2921760B2 (ja) フタルイミド誘導体及びそれら誘導体を含んでなる医薬
WO1994007480A1 (fr) Derives de polyamine utiles comme agents anti-cytomegaloviraux
US20060047171A1 (en) Catalytic hydrogenation of nitriles to produce capsaicinoid derivatives and amine compounds, and methods for purifying and obtaining the polymorphs thereof
US3382260A (en) Novel sulfonamide compounds and processes
US6624313B2 (en) Process for preparing hydroxypyrrolidinyl ethylamine compounds useful as kappa agonists

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051004

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20060214

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080526

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20080819

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20080826

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20081120

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100105

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100531